GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifecare ASA (OSL:LIFE) » Definitions » Capex-to-Revenue

Lifecare ASA (OSL:LIFE) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Lifecare ASA Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Lifecare ASA's Capital Expenditure for the six months ended in Dec. 2023 was kr0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was kr3.44 Mil.

Hence, Lifecare ASA's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.00.


Lifecare ASA Capex-to-Revenue Historical Data

The historical data trend for Lifecare ASA's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecare ASA Capex-to-Revenue Chart

Lifecare ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only - - - 0.84 0.35

Lifecare ASA Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lifecare ASA's Capex-to-Revenue

For the Medical Devices subindustry, Lifecare ASA's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecare ASA's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lifecare ASA's Capex-to-Revenue falls into.



Lifecare ASA Capex-to-Revenue Calculation

Lifecare ASA's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.215) / 3.44
=0.35

Lifecare ASA's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 3.44
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecare ASA  (OSL:LIFE) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Lifecare ASA Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lifecare ASA's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecare ASA (OSL:LIFE) Business Description

Traded in Other Exchanges
Address
Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare AS is engaged in the research and development of medical sensors for health monitoring. The company is engaged in the development, testing, and introduction of the first long-term implantable microsensor to give persons with diabetes a modern tool for the monitoring of glucose levels. It develops Sencell, a long-term implantable microsensor to give persons with diabetes a tool for monitoring of glucose levels.

Lifecare ASA (OSL:LIFE) Headlines

No Headlines